MedTrace Logo

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

NCT06488846 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-05-01

No results posted yet for this study

Summary

This study will support the expansion of long-acting injectable antiretroviral therapy (LAI-ART) in non-clinical settings by developing, implementing, and evaluating a comprehensive, theory-informed training intervention to support the administration of LAI-ART by a trained layperson injector (e.g., friend, family, partner identified by a person living with HIV). This study will address barriers to LAI-ART uptake and persistence, enhance real-world effectiveness, and help close critical HIV care gaps.

Conditions

  • HIV Infections

Interventions

OTHER

INVITE-Home

Curriculum to train Treatment Buddies, selected by the people with HIV, to administer LAI-ART at home with supervision of a Study Nurse.

DRUG

Clinic-Administered LAI-ART

People with HIV who continue to receive LAI-ART in clinic

DRUG

Oral ART

Oral ART

Sponsors & Collaborators

Principal Investigators

  • Parya Saberi, PharmD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-16
Primary Completion
2027-06-30
Completion
2027-09-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06488846 on ClinicalTrials.gov